Ye, Q., Gong, F., Shang, S., & Hu, J. (2016). Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease. Clinical immunology (Orlando, Fla.), 171, 25-31. https://doi.org/10.1016/j.clim.2016.08.012
Chicago Style (17th ed.) CitationYe, Qing, Fang-qi Gong, Shi-qiang Shang, and Jian Hu. "Intravenous Immunoglobulin Treatment Responsiveness Depends on the Degree of CD8+ T Cell Activation in Kawasaki Disease." Clinical Immunology (Orlando, Fla.) 171 (2016): 25-31. https://doi.org/10.1016/j.clim.2016.08.012.
MLA (9th ed.) CitationYe, Qing, et al. "Intravenous Immunoglobulin Treatment Responsiveness Depends on the Degree of CD8+ T Cell Activation in Kawasaki Disease." Clinical Immunology (Orlando, Fla.), vol. 171, 2016, pp. 25-31, https://doi.org/10.1016/j.clim.2016.08.012.